» Articles » PMID: 11572743

Comparison of 2 Methods for Calculating Adjusted Survival Curves from Proportional Hazards Models

Overview
Journal JAMA
Specialty General Medicine
Date 2001 Sep 27
PMID 11572743
Citations 83
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Adjusted survival curves are often presented in medical research articles. The most commonly used method for calculating such curves is the mean of covariates method, in which average values of covariates are entered into a proportional hazards regression equation. Use of this method is widespread despite published concerns regarding the validity of resulting curves.

Objective: To compare the mean of covariates method to the less widely used corrected group prognosis method in an analysis evaluating survival in patients with and without diabetes. In the latter method, a survival curve is calculated for each level of covariates, after which an average survival curve is calculated as a weighted average of the survival curves for each level of covariates.

Design, Setting, And Patients: Analysis of cohort study data from 11 468 Alberta residents undergoing cardiac catheterization between January 1, 1995, and December 31, 1996.

Main Outcome Measures: Crude and risk-adjusted survival for up to 3 years after cardiac catheterization in patients with vs without diabetes, analyzed by the mean of covariates method vs the corrected group prognosis method.

Results: According to the mean of covariates method, adjusted survival at 1044 days was 94.1% and 94.9% for patients with and without diabetes, respectively, with misleading adjusted survival curves that fell above the unadjusted curves. With the corrected group prognosis method, the corresponding survival values were 91.3% and 92.4%, with curves that fell more appropriately between the unadjusted curves.

Conclusions: Misleading adjusted survival curves resulted from using the mean of covariates method of analysis for our data. We recommend using the corrected group prognosis method for calculating risk-adjusted curves.

Citing Articles

Adjusted curves for clustered survival and competing risks data.

Khanal M, Kim S, Ahn K Commun Stat Simul Comput. 2025; 54(1):120-143.

PMID: 39790711 PMC: 11708817. DOI: 10.1080/03610918.2023.2245583.


Sphingolipid profiling as a biomarker of type 2 diabetes risk: evidence from the MIDUS and PREDIMED studies.

Berkowitz L, Razquin C, Salazar C, Biancardi F, Estruch R, Ros E Cardiovasc Diabetol. 2024; 23(1):446.

PMID: 39695759 PMC: 11657495. DOI: 10.1186/s12933-024-02505-7.


The Impact of the Approach to Accounting for Age and Sex in Economic Models on Predicted Quality-Adjusted Life-Years.

Lee D, Hart R, Burns D, McCarthy G Appl Health Econ Health Policy. 2024; 23(1):131-140.

PMID: 39320707 DOI: 10.1007/s40258-024-00918-9.


Plasma Deoxycholic Acid Levels are Associated with Hemodynamic and Clinical Outcomes in Acute Pulmonary Embolism Patients.

Sun N, Chen Y, Chen Y, Gao L, Deng R, Huang J Cardiovasc Toxicol. 2024; 24(9):879-888.

PMID: 39008240 DOI: 10.1007/s12012-024-09893-y.


Association of postpartum medication practices with early breastfeeding cessation among mothers with chronic conditions: A prospective cohort study.

Scime N, Metcalfe A, Nettel-Aguirre A, Tough S, Chaput K Acta Obstet Gynecol Scand. 2023; 102(4):420-429.

PMID: 36707933 PMC: 10008275. DOI: 10.1111/aogs.14516.